http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2727378-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_132aa5ddba376cda52c2bedb26765245
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
filingDate 2009-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1df66b4649bf83571162f881339f3d12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91f80175be39e22f49b45a82a3d2d4c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53a68813c7e20716c8b4ac3a73ea5918
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f21a9adea448b5dcfa8ff0e19900586
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0eede07c278b07c3538a8e36474e3d56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85aa20ae00cd4131d9d9dddfb7c02983
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46b0228f403298a420a20512c5b54f1c
publicationDate 2016-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2727378-C
titleOfInvention New co-crystal compound of rivaroxaban and malonic acid
abstract The present invention relates to a new co-crystal compound of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide (rivaroxaban) and malonic acid: (see formula I) (see formula II), to processes for preparing it, to medicinal products comprising it, and to the use thereof in fighting diseases.
priorityDate 2008-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID867
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565336
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID59272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45266664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410709191
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485668
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136122637
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475894
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449377322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22179027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488537
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9875401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23615413
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24179
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447561645
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474255

Total number of triples: 49.